Author

Vicko Suswidiantoro

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jan 2026

PCSK9‐Mediated Inflammation in Foam Cell Formation and Exploring the Biologically Active Compounds Derived From Natural Resources

Atherosclerosis develops as a persistent inflammatory condition that gradually alters the vascular structure and condition, in which the formation of macrophage‐derived foam cells plays a central role in disease initiation and progression. Although proprotein convertase subtilisin/kexin type 9 (PCSK9) is widely recogni...

Maharani Hestu Mukti Wisesa, Anisa Qisti Mathriul, Vicko Suswidiantoro et al. · Advances in pharmacological... · 0 citations

Open access Aug 2026

FORMULATION, OPTIMIZATION, AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF TOFACITINIB CITRATE

The objective of the present study was to study the effect of polymer on the sustained release of Tofacitinib Citrate from tablets. Compatibility was studied using Fourier transform infrared spectroscopy and UV-Visible spectroscopy. The tablets were prepare using the wet granulation method using HPMC K4M and Xanthan gu...

Meghana Raykar, G. Asane, S. Darekar et al. · Genetics and Molecular Resea... · 0 citations

Review Open access Aug 2026

Role of PCSK9 in breast cancer: a systematic review of its mechanistic pathways and clinical relevance

Introduction Breast cancer is a heterogeneous disease in which accurate classification based on biomarker expression is essential for effective therapeutic decision-making. Consequently, the identification of novel biomarkers remains a research priority. Proprotein convertase subtilisin/kexin type 9 (PCSK9), a key regu...

M. U. Puteri, Vicko Suswidiantoro, Rahma Nabila et al. · Frontiers in Pharmacology · 0 citations